Sichuan Hebang Biotechnology Co (SHSE:603077) Accounts Payable: ¥885 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603077 Sichuan Hebang Biotechnology Co Ltd SHSE:603077
53 GF Score
Price ¥2.37
GF Value ¥1.27
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Sichuan Hebang Biotechnology Co Accounts Payable?

Sichuan Hebang Biotechnology Co SHSE:603077 -0.42% 53 Accounts Payable is ¥885 Mil as of Jun. 2026. GuruFocus rates SHSE:603077 with a GF Score™ of 53/100 and a GF Value™ of ¥1.27 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Sichuan Hebang Biotechnology Co's Accounts Payable for the quarter that ended in Jun. 2026 was ¥885 Mil.

Sichuan Hebang Biotechnology Co's quarterly Accounts Payable declined from Dec. 2025 (¥931 Mil) to Mar. 2026 (¥801 Mil) but then increased from Mar. 2026 (¥801 Mil) to Jun. 2026 (¥885 Mil).

Sichuan Hebang Biotechnology Co's annual Accounts Payable increased from Dec. 2023 (¥1,877 Mil) to Dec. 2024 (¥2,108 Mil) but then declined from Dec. 2024 (¥2,108 Mil) to Dec. 2025 (¥931 Mil).

Sichuan Hebang Biotechnology Co Accounts Payable Related Terms

Sichuan Hebang Biotechnology Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for Sichuan Hebang Biotechnology Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sichuan Hebang Biotechnology Co Accounts Payable Chart

Sichuan Hebang Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,156.14 1,877.49 1,877.50 2,107.64 930.52

Sichuan Hebang Biotechnology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,225.23 983.53 930.52 801.48 884.65
SHSE:603077
53GF Score
Sichuan Hebang Biotechnology Co Ltd SHSE:603077
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sichuan Hebang Biotechnology Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ¥885 Mil mean?
Sichuan Hebang Biotechnology Co (SHSE:603077) has a Accounts Payable of ¥885 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Sichuan Hebang Biotechnology Co and its competitors.
Is Sichuan Hebang Biotechnology Co's Accounts Payable too high?
Sichuan Hebang Biotechnology Co's current Accounts Payable is ¥885 Mil. Overall, Sichuan Hebang Biotechnology Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sichuan Hebang Biotechnology Co's Accounts Payable compare to DOW?
Sichuan Hebang Biotechnology Co's Accounts Payable of ¥885 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Chemicals company?
A good Accounts Payable depends on the Chemicals industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Sichuan Hebang Biotechnology Co and its competitors. Sichuan Hebang Biotechnology Co's current Accounts Payable is ¥885 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sichuan Hebang Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Sichuan Hebang Biotechnology Co (SHSE:603077) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.27, compared to a current price of ¥2.37 — trading 86.6% above its estimated fair value. The current Accounts Payable is ¥885 Mil. Sichuan Hebang Biotechnology Co's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Sichuan Hebang Biotechnology Co (SHSE:603077), the current Accounts Payable is ¥885 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sichuan Hebang Biotechnology Co (SHSE:603077) Overvalued in 2026?

Based on GuruFocus' analysis, Sichuan Hebang Biotechnology Co stock appears to be overvalued. The current stock price of ¥2.37 is trading 86.6% above its estimated GF Value™ of ¥1.27. GuruFocus considers Sichuan Hebang Biotechnology Co to be Significantly Overvalued.

Key valuation signals for SHSE:603077:

  • Accounts Payable: ¥885 Mil
  • GF Value™: ¥1.27 vs. price of ¥2.37 (86.6% above fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the SHSE:603077 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sichuan Hebang Biotechnology Co Business Description

Address Mianba Village, Niuhua Town, Wutongqiao District, Sichuan, Leshan, CHN, 614801
Sichuan Hebang Biotechnology Co Ltd is engaged in Chemical manufacturing and development of salt mines and phosphate mines.
53GF Score

Get the complete analysis for SHSE:603077

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.37
Price
¥1.27
GF Value